Trevi Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.95 | $56.28 M | -5.86 | 2 | $0 |
 ANTX
|
AN2 Therapeutics, Inc. | $1.06 | $60.55 M | -0.81 | 41 | $0 |
 BCAB
|
BioAtla, Inc. | $2.21 | $73.14 M | -0.61 | 65 | $0 |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.65 | $29.02 M | -0.46 | 100 | $7.88 M |
 CCCC
|
C4 Therapeutics, Inc. | $5.40 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $16.32 | $1.29 B | -7.16 | 85 | $0 |
 CHRS
|
Coherus BioSciences, Inc. | $1.05 | $193.89 M | -2.28 | 246 | $257.24 M |
 CUE
|
Cue Biopharma, Inc. | $1.16 | $71.99 M | -1.38 | 53 | $5.49 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 FHTX
|
Foghorn Therapeutics Inc. | $7.87 | $332.53 M | -2.73 | 116 | $34.16 M |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.24 | $19.53 M | -0.27 | 88 | $1.56 M |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 ORIC
|
ORIC Pharmaceuticals, Inc. | $9.62 | $595.34 M | -4.91 | 107 | $0 |
 PRLD
|
Prelude Therapeutics Incorporated | $2.00 | $205.99 M | -2.02 | 128 | $0 |
 RZLT
|
Rezolute, Inc. | $4.96 | $229.57 M | -5.02 | 51 | $0 |
 SEER
|
Seer, Inc. | $1.99 | $112.34 M | -1.34 | 147 | $15.18 M |
 SPRO
|
Spero Therapeutics, Inc. | $1.30 | $75.85 M | 3.19 | 46 | $96.74 M |
 SQZ
|
SQZ Biotechnologies Company | $0.44 | $12.83 M | -0.2 | 53 | $21.03 M |
 TARA
|
Protara Therapeutics, Inc. | $1.78 | $54.98 M | -0.71 | 26 | $0 |
 TCON
|
TRACON Pharmaceuticals, Inc. | $0.11 | $3.05 M | 0.01 | 17 | $12.05 M |